Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Remeditex Ventures

Remeditex Ventures
VC INVESTOR TYPE
Active STATUS
3 PROFESSIONALS
21 INVESTMENTS
7 PORTFOLIO
9 EXITS
Description

Remeditex Ventures is a venture capital firm based in Dallas, Texas. The firm prefers to invest in entrepreneurial ecosystems and early-stage companies operating in the life sciences, biomedical sciences and biotechnology sectors.

Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
  • 2101 Cedar Springs
  • Suite 601
  • Dallas, TX 75201
  • United States

+1 (214) 000-0000

Remeditex Ventures Investments (21)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
ReCode Therapeutics 08-Feb-2019 Early Stage VC 000 Drug Delivery Generating Revenue
00000 000000000000 25-Jan-2018 000 00000 Drug Delivery Generating Revenue/Not Profitable 0000 000000
00000 000000000000 18-Sep-2017 00000 00000 0000 Drug Discovery Product Development 0000 000000
00000 000000000000 28-Jul-2017 00000 00000 000.00 Drug Delivery Generating Revenue/Not Profitable 0000 000000
0000000 0000000000 14-Mar-2017 00000 00000 000.00 Pharmaceuticals Clinical Trials - Phase 2 0000 000000
0000000 0000000000 13-Feb-2017 0000 000.00 Biotechnology Profitable 0000 000000
0000000 0000000000 31-Oct-2016 00000 00000 0000 Biotechnology Profitable 0000 000000
0000000 0000000000 18-Dec-2015 00000 00000 0000 Biotechnology Generating Revenue 00000 00000000 00
miRagen Therapeutics 30-Oct-2015 Later Stage VC 000.00 Biotechnology Profitable 0000 000000
Quartet Medicine 07-Oct-2015 Early Stage VC 000.00 Biotechnology Out of Business 0000 000000
To view this investor’s complete investment and acquisition history, request access »
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Remeditex Ventures’s full profile, request a free trial.

Remeditex Ventures Exits (7)

Company Name Exit Date Exit Type Exit Size Status Buyers
Bio2 Medical 01-Sep-2018 Out of Business Completed
0000000 00000000 20-Nov-2017 000 00 00000000 Completed
000000 00000000000 29-Dec-2016 0000000 000000 Completed
0000000 0000000000 12-Sep-2016 000000000000000000 Completed
  • 0000 0000000000
00000000 000000000 01-Apr-2016 000000000 00000000 Completed
VuCOMP 13-Jan-2016 Merger/Acquisition Completed
Bellicum Pharmaceuticals 17-Dec-2014 IPO 00000 Completed
To view this investor’s complete exits history, request access »

Remeditex Ventures Team (6)

Name Title Deals Funds Boards Office Contact
Info
John Creecy Chief Executive Officer & Director 00 0 Dallas, TX
Brett Ringle JD President & Director 0 Dallas, TX
John Elwood Vice President, Business Development Dallas, TX
Claire Aldridge Ph.D Vice President, Venture Development Dallas, TX

2 Former Team Members

You’re viewing 4 of 6 team members. Get the full list »